CCR4 antagonist 2 |
カタログ番号GC35626 |
CCR4 アンタゴニスト 2 (化合物 31) は、CC ケモカイン受容体 4 (CCR4) の新しい強力な経口生物学的利用可能な低分子アンタゴニストであり、健康な組織の Treg の数を抑制することなく、腫瘍微小環境への Treg の輸送を阻害します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2206788-99-8
Sample solution is provided at 25 µL, 10mM.
CCR4 antagonist 2 (Compound 31) is a novel potent, orally bioavailable small molecule antagonists of CC chemokine receptor 4 (CCR4) that inhibits Treg trafficking into the Tumor Microenvironment without suppressing the number of Treg in healthy tissues.CCR4 antagonist 2 (Compound 31) exhibits IC50 values of Ca2+flux and (chemotaxis) CTX are 40 nM and 70 nM, respectively[1]. IC50: 40 nM (Ca2+flux); 70 nM (CTX) (CCR4 antagonist 2)[1]
[1]. Jackson JJ, et al. Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor Microenvironment. J Med Chem. 2019 Jul 11;62(13):6190-6213.
Average Rating: 5
(Based on Reviews and 31 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *